Orexigen

The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32
[video]How Bad Is This Delay for Orexigen Therapeutics, Inc?
Motley Fool
Tue, 06/24/14 - 09:12 am
Contrave
FDA
obesity
Orexigen
Is It Time to Buy Orexigen?
Motley Fool
Sat, 06/14/14 - 09:20 am
Orexigen
Arena's Belviq Sales Do More Than Recover
Seeking Alpha
Fri, 06/13/14 - 03:05 pm
Arena Pharmaceuticals
Belviq
obesity
Orexigen
Contrave
FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock
Seeking Alpha
Wed, 06/11/14 - 09:50 am
FDA
obesity
Orexigen
Contrave
Orexigen Could Be A Double-Edged Sword For Arena
Seeking Alpha
Mon, 06/9/14 - 07:46 pm
Orexigen
Arena Pharmaceuticals
Contrave
obesity
Belviq
Orexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision Wednesday
TheStreet.com
Mon, 06/9/14 - 01:20 pm
Orexigen
obesity
FDA
Contrave
Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why
Seeking Alpha
Wed, 05/28/14 - 09:45 am
obesity
Orexigen
FDA
Contrave
Vivus
Qsymia
Belviq
Arena Pharmaceuticals
Arena To Present At Jefferies Conference - Is It A Catalyst?
Seeking Alpha
Tue, 05/27/14 - 09:19 pm
Arena Pharmaceuticals
obesity
Orexigen
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
Tue, 05/27/14 - 11:53 am
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
Wider-than-Expected Loss at Orexigen in Q1
Yahoo/Zacks.com
Mon, 05/12/14 - 09:42 am
Orexigen
earnings
Will Arena Seize An Opportunity?
Seeking Alpha
Tue, 05/6/14 - 04:46 pm
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
obesity
Qsymia
Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration
Seeking Alpha
Wed, 03/26/14 - 04:58 pm
Vivus
Qsymia
Orexigen
Contrave
Belviq
Arena Pharmaceuticals
Biotech Tweets of the Week: Gilead Sciences and Orexigen
Motley Fool
Sat, 03/22/14 - 11:32 am
Gilead Sciences
Orexigen
Orexigen looking for FDA approval in next few months, says Cowen
Yahoo/Fly on the Wall
Thu, 03/13/14 - 10:29 am
Orexigen
obesity
Contrave
FDA
Orexigen Therapeutics Reduces Q4 Loss by 34%
Motley Fool
Thu, 03/13/14 - 09:44 am
earnings
Orexigen
Have Anti-Obesity Drug Companies Failed?
Seeking Alpha
Fri, 03/7/14 - 03:56 pm
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Orexigen Sees Positives In European Application For Contrave
Seeking Alpha
Wed, 02/26/14 - 09:08 am
Contrave
Europe
obesity
Orexigen
Cheaper Obesity Drugs Available (for Half of Some Americans)
Daily Finance
Mon, 02/24/14 - 05:25 pm
obesity
Arena Pharmaceuticals
Eisai
Vivus
Orexigen
Belviq
Qsymia
Contrave
Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc.
Motley Fool
Fri, 02/21/14 - 10:44 am
obesity
Arena Pharmaceuticals
Vivus
Belviq
Qsymia
Novo Nordisk
Orexigen

Pages